β-HCG as a Tumor Biomarker with Special Reference to Breast Cancer
Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2017, Vol 1, Issue 2
Abstract
Introduction Human chorionic gonadotropin (HCG) is a placental protein hormone initially secreted by cells (syncitiotrophoblasts) from the implanting conceptus. It supports the ovarian corpus luteum, endometrial lining and consequently maintains pregnancy [1]. The hormone can be detected in blood and urine, as it is the basis of many pregnancy tests. HCG plays many other roles including stimulating the onset of fetal gonadal steroidogenesis, promotion production of corpus luteal progesterone, immuno-suppression and blockage of phagocytosis of invading trophoblast cells, cytotrophoblast differentiation, growth and differentiation of fetal organs [2]. It is well known that a biomarker is any molecular and chemical changes that can be measured and used to study normal or abnormal process in the body. A tumor marker, like a biomarker, is a naturally occurring substance in the body. A tumor marker can be made by cancer cells or by the body in response to cancer. Tumor markers can provide information that can be used to screen and diagnose cancer as well as identify the stage of cancer to monitor a treatment [3]. It was reported that although mammography, ultrasonography, computed tomography, magnetic resonance imaging scans, and tumor marker assays help in the staging and treatment of cancers, they are usually not definitive diagnostic tests. The diagnosis is mostly confirmed by biopsy [4]. Human chorionic gonadotropin is a glycoprotein composed of 237 amino acids, with α subunit (92 amino acids) and β subunit contains 145 amino acids. It can be used as a tumor marker, as its β subunit is secreted by cell tumor [5]. Breast cancer is the most often diagnosed tumor of women and one of the leading causes of death. The effect of human chorionic gonadotropin on development of cancer is controversial. In fact, for breast cancer there is evidence that this hormone has a protective effect against tumor genesis due the differentiation of the mammary tissue after a full term pregnancy through the down regulation of estrogen receptors. The mechanisms that explain the pro- and anticarcinogenic effects are not fully understood yet [6]. HCG increases uterine arterial blood flow and stimulates angiogenesis in the ovary by stimulating the proliferation of vascular endothelial cells and the expression of vascular endothelial growth factor [7]. It was concluded that high expression of β-HCG is seen more frequently in infiltrative ductal carcinoma with higher grade. There was a high β -HCG expression in high grade tumors of more than 5-cm diameter [8]. The beta subunit of human’s chronic gonadotropin is markedly over expressed by neoplastic cells of differing histological origin including those present in colon, breast, prostate and bladder tumors [9].
Authors and Affiliations
Rafal Al Rawi
Keywords
Related Articles
- EP ID EP569289
- DOI 10.26717/BJSTR.2017.01.000234
- Views 175
- Downloads 0
Origin of Asexual Reproduction in Hydra
Hydra's buds develop through the integrated activity of two different types of cells: a) Epithelial (aka epithelial-muscular) cells forming the didermic body wall (with extension into tentacles, hypostome, and foot) and...
Phase-Down of Amalgam Use in Dentistry: A Perspective For its Effective Control and Management
Mercury pollution of the environment and its negative impacts on the health of humans had been recognized many years ago by the world community; and the contribution of dental amalgam, which contains about 50% of mercury...
Darbepoetin Alpha For the Treatment of Anemia in Systemic Mastocytosis
Human systemic mastocytosis (SM) is a rare disease caused by an abnormal mast cells accumulation in various tissues. The most aggressive forms have a rapid course and required treatments to reduce the neoplastic burden a...
Evaluation of a protection system for livestock during transport: PROGAT® from the animal welfare point of view
Transport of livestock constitute a large welfare problem in most of South American countries. With the aim to provide a solution and applying the knowledge of the automotive and metal-mechanic industry, a device was des...
Peripheral Arterial Disease in Patients with Atrial Fibrillation
Peripheral Arterial Disease (PAD) is defined as a systemic atherosclerotic disease, which occurs due to narrowing and obstruction of major systemic arteries other than coronary arteries and aorta. It affects 200 million...